The Rheumatologist

Despite anecdotal reports to the contrary, a large observational study concludes that TNF inhibitors, compared with non-TNF biological or targeted […]

The ARP & the Rheumatology Research Foundation are key partners in advancing rheumatology. Learn how they support care, training &

My gray-haired, heavily moustachioed patient shot me a wry smile and a very slight nod under his cowboy hat. I

Pediatric rheumatologic diseases are characterized by high rates of anxiety & depression known to impact health-related outcomes. CARRA and the

The 2026 Community Practice Innovation Award supports projects that enhance care delivery, improve outcomes and address real-world challenges in rheumatology.

With resources and programs running online and on-the-ground in 47 states, COIN’s projects are having a massive impact on the

In a powerful op-ed published by Fierce Healthcare, rheumatologists Amanda Myers, MD, and Rebecca Shepherd, MD, MBA—both volunteer advocates with

If physicians and other healthcare workers are not exempted from the $100,000 fee, the rheumatology workforce may be negatively affected,

In the wake of unprecedented federal research cuts, the new $1 million emergency funding commitment aims to protect vital projects

At ACR Convergence 2025, the ACR advocacy team will be hosting a slate of programming to help you understand the

The ACR recently led a rheumatology community letter to Cigna opposing the payer’s decision to downcode level 4 and 5

The early initiation of biologic disease-modifying anti-rheumatic drugs (DMARDs) may reduce the overall disease burden in patients with polyarticular juvenile

In this episode, Dr. Kumar talks about the fascinating and intriguing secret lives of rheumatologists—real life superheroes. The post <em>Rheum

The ACR’s delegation to the American Medical Association’s House of Delegates is gearing up for the HOD Interim Meeting, slated

Two upcoming surveys of ACR members will help identify trends and issues affecting academic and private practice rheumatology, as well

Telehealth is at risk. Congress must act before the end of September to maintain vital flexibility and reimbursement for telemedicine

ACR President Carol Langford, MD, MHS, is making headlines as a leading voice in the fight against proposed Medicare reimbursement

The Federal Trade Commission is seeking input about the use and impacts of noncompete agreements, with particular interest in the

All vaccines recommended by the CDC’s ACIP)as of Sept. 1, 2025 — including updated COVID-19 and influenza shots — will

MIPS-eligible clinicians should review their scores to confirm performance. Any scoring concerns can be addressed through a targeted review The

The FDA will consider a supplemental new drug application for deucravacitinib for the treatment of adults with active psoriatic arthritis

The FDA has approved a new drug application for TNX-102 SL (Tonmya), a tablet with 2.8 mg of cyclobenzaprine HCl,

Dr. Amish Dave discusses how his volunteer, advocacy & public outreach work stem from his greater commitment to community &

A rheumatologist & lupus expert reviews lupus nephritis treatment, questioning proteinuria cutoffs & ACR guidelines, advocating for newer therapies &

SLE treatment is rapidly evolving as new therapies are developed & approved. Here are 10 key insights for clinicians. The

A second-year internal medicine resident shares five ACR resources (plus an app) for residents navigating the complexities of rheumatology. The

Avoidable Hospitalizations in Patients with RA By Dani G. Contreras, MSc, & Cheryl Barnabe, MD, MSc, FRCPC Why was this